Norman Brito-Dellan, M.D.
Department of Hospital Medicine, Division of Internal Medicine
Present Title & Affiliation
Primary Appointment
Associate Professor, Department of Hospital Medicine, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Program Director, Onco-Hospitalist Fellowship Program, Department of Hospital Medicine, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 1994 | Central University of Venezuela, "Luis Razetti" School of Medicine, Caracas, VEN, MD, Medicine |
Postgraduate Training
| 2010-2012 | Clinical Safety and Effectiveness Program, The University of Texas MD Anderson Cancer Center, Houston, TX |
| 2001-2002 | Clinical Fellowship, Hospice and Palliative Medicine, Cleveland Clinic Foundation, Cleveland, OH |
| 1998-2001 | Clinical Residency, Internal Medicine, Categorical Internal Medicine Residency Program, University of Utah, Salt Lake City, UT |
Board Certifications
| 2012 | American Board of Internal Medicine in Hostpital Medicine |
| 2010 | American Board of Hospice and Palliative Medicine |
| 2001 | American Board of Internal Medicine |
Experience & Service
Academic Appointments
Assistant Professor, Department of Hospital Medicine, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2011 - 2019
Administrative Appointments/Responsibilities
Project Director, Oncologic Hospitalist Fellowship Program, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2017 - 2020
Medical Director, Palliative Care Program, Dixie Regional Medical Center, St. George, UT, 2010 - 2011
Medical Director, Intermountain Home Care and Hospice, St. George, UT, 2007 - 2011
Medical Director, Zion's Way Hospice, St. George, UT, 2005 - 2006
Medical Director, Odyssey Hospice, St. George, UT, 2005 - 2006
Medical Director, Southwest Utah Community Health Center, St. George, UT, 2003 - 2006
Medical Director, Southwest Utah Public Health Department, St. George, UT, 2003 - 2006
Honors & Awards
| 2015 | MASCC Fatigue Study Group Outstanding Junior Investigator Research Award, MASCC |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Dickson K, Koom-Dadzie K, Brito-Dellan N, Escalante C. Risks, diagnosis, and management of recurrent cancer-associated thrombosis (CAT): a narrative review. Support Care Cancer 30(10):8539-8545, 2022. e-Pub 2022. PMID: 35699781.
- Font C, de Herreros MG, Tsoukalas N, Brito-Dellan Nb||, Espósito F, Escalante C, Oo TH, MASCC Hemostasis Study Group. Thrombotic microangiopathy (TMA) in adult patients with solid tumors: a challenging complication in the era of emerging anticancer therapies. Support Care Cancer. e-Pub 2022. PMID: 35545722.
- Saunders DP, Rouleau T, Cheng K, Yarom N, Kandwal A, Joy J, Bektas Kayhan K, van de Wetering M, Brito-Dellan N, Kataoka T, Chiang K, Ranna V, Vaddi A, Epstein J, Lalla RV, Bossi P, Elad S, Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO). Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care Cancer 28(5):2473-2484, 2020. e-Pub 2020. PMID: 32052137.
- Gonzalez CE, Brito-Dellan N, Banala SR, Rubio D, Ait Aiss M, Rice TW, Chen K, Bodurka DC, Escalante CP. Handoff Tool Enabling Standardized Transitions Between the Emergency Department and the Hospitalist Inpatient Service at a Major Cancer Center. Am J Med Qual 33(6):629-636, 2018. e-Pub 2018. PMID: 29779398.
- Khan MI, Walsh D, Brito-Dellan N. Opioid and Adjuvant Analgesics: Compared and Contrasted. Am J Hosp Palliat Care 28(5):378-83, 2011. e-Pub 2011. PMID: 21622486.
- Srivastava M, Brito-Dellan, Nb||, Davis MP, Leach M, Lagman R. Olanzapine as an antiemetic in refractory nausea and vomiting in advanced cancer. J Pain Symptom Manage 25(6):578-582, 2003. PMID: 12782438.
Abstracts
- Brito-Dellan, Gaudel P. Uncommon and Potentially Life-Threatening Complications from the Immune Checkpoint-Inhibitor Nivolumab at an Onco-Hospitalist Inpatient Service. MASCC 2019. San Francisco, CA. Supportive Care in Cancer (2019) 27(Suppl 1): S1-S302. https://doi.org/10.1007/s00520-019-04813-1, 2019.
- Brito-Dellan N, Gaudel P. A Rapidly Growing Gigantic Squamous Cell Carcinoma of the Upper Eyelid in an Elderly Hospice Patient. MASCC 2019. San Francisco, CA. Supportive Care in Cancer (2019) 27(Suppl 1): S1-S302, 2019.
- Brito-Dellan N, Oo T, Rojas Hernandez C, Blum-Murphy M. A Case of Nivolumab-Induced Myositis and Myasthenia Gravis. MASCC 2019. San Francisco, CA. Supportive Care in Cancer (2019) 27(Suppl 1): S1-S302 https://doi.org/10.1007/s00520-019-04813-1, 2019.
- Brito-Dellan N, Gaudel P. Onco-Hospitalists and their increasing role in cancer patient care. GAP, 2019.
- Makawita S, Brito-Dellan N, Mulanovich V. Atypical mycobacterium lymphadenitis - a goodii mimicker of malignancy. Division of Internal Medicine 2018 Research Retreat, The University of Texas MD Anderson Cancer Center, 2018.
- Gonzalez CD, Brito-Dellan N, Banala SR, Rubio D, Ait Aiss M, Rice TW, Chen K, Bodurka DC, Escalante CP. Modified Tool Enabling Standard Transitions of Care Between the Emergency Department and the Hospitalist Inpatient Service at a Major Cancer Center. Division of Internal Medicine 2017 Research Retreat, The University of Texas MD Anderson Cancer Center, 2017.
- S Banala, CE Gonzalez, N Brito-Dellan, D Rubio. Safer Transitions of Care at a Major Cancer Center: The Emergency Center to Hospitalist Experience. ASCO Annual Meeting, 2016.
- N Brito-Dellan. Utilizing Electronic Technologies to Measure Patient-Reported Outcomes (PRO) Assessment Completion Time. 2016 Palliative Care in Oncology Symposium, San Francisco, CA, 2016.
- N Brito-Dellan. Toxicities of the Ani-PD-1 Immune Checkpoint Antibody Nivolumab in the Acute Inpatient Setting. 2016 Palliative Care in Oncology Symposium, San Francisco, CA, 2016.
- Diane C. Bodurka, Mohamed Ait Aiss, Helene P. Phy, Laeisha R. Day, Varkey Abraham, Karen Chen, Mejia Rodrigo, Shela Razvi, Carmen E. Gonzalez, Norman Brito-Dellan, Srinivas Banala, David Rubio, Nicole Vaughan-Adams, Debra S. Ruiz, Tan Jens, Charles F. Levenback, Michael M. Frumovitz, Behrouz Z and,Carmelita P. Escalante. Improving Transitions of Care Through Implementation of a Standardized Handoff at a Comprehensive Cancer Center. J Clin Oncol 34, 2016 (suppl 7S; abstr 242) 2016 ASCO Quality Care Symposium Meeting, 2016.
- Brito-Dellan N; Lam, Tony; Manzullo, Ellen; Kallen, Michael; Yang, Dershung; Haas , Nina; Escalante, Carmen. Utilizing Electronic Technologies to Measure PRO Assessment Completion Time in a Clinical Practice, 2015.
- Escalante, C; Elting, L; Halm, J; Zalpour A; Bossi, P; Yusuf S; Brito-Dellan N, Sahai Sl; Bhadriraju S; Rouleau T; Chang Y. Meta-analysis: Risk of Congestive Heart Failure (CHF) in Selected Targeted Agents, 2015.
- Brito-Dellan N. Adjuvant Analgesics in the Acute Inpatient Setting, 2013.
- George M; Hollenberg C; Terrell J;Brito-Dellan N, Brown K; DiMonda D; Halm J; Palla S; Lavis V; Yang A. Standardizing Insulin Management in the Hospitalized Cancer Patient, 2012.
Book Chapters
- Brites M, Brito-Dellan N. Apothecarius 1995 - 1996. In: Bromocriptina, 83-85, 1995.
Patient Reviews
CV information above last modified June 20, 2024